{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:05:45Z","timestamp":1762999545501,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Boehringer Ingelheim"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.hrthm.2019.11.025","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T11:34:04Z","timestamp":1575027244000},"page":"560-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational study"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-3854","authenticated-orcid":false,"given":"Peter Vibe","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7287-4191","authenticated-orcid":false,"given":"Frederik","family":"Dalgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Hilmar Gislason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8784-9714","authenticated-orcid":false,"given":"Maria","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1541-309X","authenticated-orcid":false,"given":"Martin H.","family":"Ruwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannik Langtved","family":"Pallisgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten Lock","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2019.11.025_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0885066613503278","article-title":"Amiodarone-induced thyroid dysfunction","volume":"30","author":"Danzi","year":"2015","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.hrthm.2019.11.025_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.JAA.0000524713.17719.c8","article-title":"Amiodarone-induced pulmonary toxicity","volume":"30","author":"Colby","year":"2017","journal-title":"JAAPA"},{"key":"10.1016\/j.hrthm.2019.11.025_bib3","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.12659\/MSM.890881","article-title":"Cutaneous adverse reactions of amiodarone","volume":"20","author":"Jaworski","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.hrthm.2019.11.025_bib4","article-title":"Adherence to monitoring guidelines of amiodarone adverse reactions","volume":"6","author":"Lavon","year":"2019","journal-title":"Health Serv Res Manag Epidemiol"},{"key":"10.1016\/j.hrthm.2019.11.025_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11096-018-0698-5","article-title":"Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone","volume":"40","author":"Ye","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.hrthm.2019.11.025_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","article-title":"Clinical pharmacokinetics of amiodarone","volume":"9","author":"Latini","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.hrthm.2019.11.025_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.5858\/2004-128-807-ATATCC","article-title":"Amiodarone-induced thyrotoxicosis and thyroid cancer: clinical, immunohistochemical, and molecular genetic studies of a case and review of the literature","volume":"128","author":"Saad","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.hrthm.2019.11.025_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2230.1990.tb02102.x","article-title":"Amiodarone-induced photosensitivity and basal-cell carcinoma","volume":"15","author":"Monk","year":"1990","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.hrthm.2019.11.025_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000333697","article-title":"Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report","volume":"21","author":"Inaba","year":"2012","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.hrthm.2019.11.025_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1365-4632.2008.03819.x","article-title":"Amiodarone-induced skin pigmentation and multiple basal-cell carcinomas","volume":"48","author":"Maoz","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.hrthm.2019.11.025_bib11","article-title":"Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts","volume":"10","author":"Lim","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.hrthm.2019.11.025_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.93.2.425","article-title":"Amiodarone pulmonary toxicity presenting as a solitary lung mass","volume":"93","author":"Arnon","year":"1988","journal-title":"Chest"},{"year":"2004","series-title":"Medication Guide: Amiodarone HCl","key":"10.1016\/j.hrthm.2019.11.025_bib13"},{"key":"10.1016\/j.hrthm.2019.11.025_bib14","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/cncr.27881","article-title":"Amiodarone and the risk of cancer: a nationwide population-based study","volume":"119","author":"Su","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.hrthm.2019.11.025_bib15","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehp100","article-title":"Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials","volume":"30","author":"Piccini","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.11.025_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2019.11.025_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.hrthm.2019.11.025_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1403494810393562","article-title":"The Danish Cancer Registry","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.hrthm.2019.11.025_bib20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A Class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.hrthm.2019.11.025_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.hrthm.2019.11.025_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.amjmed.2015.08.039","article-title":"Practical management guide for clinicians who treat patients with amiodarone","volume":"129","author":"Epstein","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2019.11.025_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/157016108784912019","article-title":"Amiodarone hepatotoxicity","volume":"6","author":"Babatin","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.hrthm.2019.11.025_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-0029-1240011","article-title":"Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use","volume":"29","author":"Raja","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hrthm.2019.11.025_bib25","doi-asserted-by":"crossref","first-page":"13390","DOI":"10.18632\/oncotarget.24385","article-title":"Amiodarone promotes cancer cell death through elevated truncated SRSF3 and downregulation of miR-224","volume":"9","author":"Chang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.hrthm.2019.11.025_bib26","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2016.16435","article-title":"Confounding by indication in clinical research","volume":"316","author":"Kyriacou","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.11.025_bib27","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.11.025_bib28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0002-8703(85)90238-8","article-title":"Side effects and complications of amiodarone therapy","volume":"109","author":"Raeder","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2019.11.025_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1540-8159.1998.tb01068.x","article-title":"Adverse effects of amiodarone","volume":"21","author":"Jafari-Fesharaki","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"issue":"Suppl 2","key":"10.1016\/j.hrthm.2019.11.025_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/CLEP.S31574","article-title":"Completeness of breast cancer staging in the Danish Cancer Registry, 2004-2009","volume":"4","author":"Ording","year":"2012","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2019.11.025_bib31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/EDE.0000000000000802","article-title":"Melanoma of the skin in the Danish Cancer Registry and the Danish Melanoma Database: a validation study","volume":"29","author":"Pedersen","year":"2018","journal-title":"Epidemiology"},{"key":"10.1016\/j.hrthm.2019.11.025_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009543","article-title":"Atrial fibrillation and risk of cancer: a Danish population-based cohort study","volume":"7","author":"Vinter","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119310884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119310884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:50:14Z","timestamp":1761547814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527119310884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1547527119310884"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.11.025","relation":{},"ISSN":["1547-5271"],"issn-type":[{"type":"print","value":"1547-5271"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational study","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}